GET DAILY SIGNALSSono-Tek Corporation (SOTK) Falls -39% Over 30 Days After Earnings Miss
Key Takeaways
- Sono-Tek Corporation shares have declined roughly 39% over the past 30 days, falling from a mid-October high near $7.16 to about $4.36.
- The drop reversed a sharp rally that had carried the stock to a 52-week high and roughly 50% year-to-date gains.
- The primary catalyst was a fiscal second-quarter (FY2027) earnings report that missed revenue and earnings-per-share (EPS) consensus, while management reaffirmed flat-to-modest full-year growth guidance.
- Medical-market sales surged 209% in the quarter, but soft alternative/clean-energy demand tied to U.S. policy shifts continued to weigh on the revenue mix.
- A rich valuation—roughly five times trailing revenue and more than 45 times trailing earnings at the peak—left little room for disappointment.
- For additional detail, explore Sono-Tek's Price Targets and Forecast on dedicated pages.
- Discover new opportunities with Trending AI Robots.
Understanding Sono-Tek Corporation (SOTK) and Its Markets
SOTK represents the common stock of Sono-Tek Corporation, a Nasdaq-listed micro-cap industrial technology firm rather than a diversified exchange-traded fund. Based in Milton, New York, the company focuses on precision ultrasonic spray coating systems for thin-film applications across multiple sectors. Its revenue mix effectively serves as its portfolio exposure, with fiscal 2026 results showing alternative/clean energy at roughly 38% of sales, electronics/microelectronics near 30%, medical around 24%, and the rest from industrial and R&D uses. Multi-axis and in-line coating systems drove most revenue, supported by OEM systems, fluxing equipment, and services. The firm posted record net sales of about $20.9 million that year, a 51% gross margin, and net income of roughly $1.8 million, all while maintaining no long-term debt and holding about $17.7 million in cash and securities.
Recent Price Action: The 30-Day Decline and Quarterly View
Over the past 30 days, SOTK has dropped approximately 39%, moving from a closing high near $7.16 down to about $4.36. The decline came quickly after a mid-October peak, erasing gains from an earlier rally. Looking back three months, the picture shows a milder drop of roughly 15% from levels near $5.15 in early August. The period featured a strong climb of more than 60% from early September into mid-October, followed by the reversal. I checked this using Tickeron’s AI Screener to compare the stock’s momentum against peers. This pattern highlights how momentum buying in a high-multiple name can unwind fast once expectations shift.
The Earnings Catalyst Behind the Recent Move
The main trigger was the fiscal second-quarter (FY2027) results, which came in below consensus on both revenue and EPS. Net sales rose just 1% year over year to $5.23 million, missing the roughly $5.5 million expected, while EPS of $0.02 fell short of the approximately $0.04 estimate. Management kept full-year guidance at flat to modestly higher revenue, which disappointed investors who had priced in faster growth. Medical sales jumped 209% to $3.11 million, or about 59% of quarterly revenue, thanks to balloon-coating and stent systems. Yet alternative-energy revenue softened due to lower electrolysis and green-hydrogen demand amid U.S. policy changes. A large $7.19 million clean-energy order was announced post-quarter, but most shipments are slated for fiscal 2028. At the peak, the stock traded at roughly five times trailing revenue and over 45 times trailing earnings, so the miss led to quick multiple compression.
Quarterly Trends and Broader Drivers
Over the three-month span, the stock reflected shifting end-market dynamics and sentiment changes. Early strength came from medical momentum and a 23% sequential backlog rise to $9.51 million. First-half fiscal 2027 revenue grew 6% to $10.89 million, with gross margin expanding to 55% and operating income up 41%. I also reviewed this using Tickeron’s AI Trend Prediction Engine to assess the underlying patterns. Still, revenue concentration in high-ASP systems makes results lumpy, and clean-energy policy uncertainty kept guidance conservative. Thin analyst coverage added to the vulnerability once momentum faded, resulting in the round-trip price action.
Looking Ahead for SOTK Investors
Key items to watch include conversion of the order book into revenue, with more than $10.7 million in backlog largely tied to fiscal 2028 deliveries. The medical segment’s growth trajectory and any recovery in clean-energy demand will matter, as will gross-margin sustainability after the strong first-half 55% level. The debt-free balance sheet and cash position support planned capacity expansion, though execution risks remain for a micro-cap with concentrated orders. Quarterly volatility looks set to continue.
My Take on Using Tickeron’s AI Tools
In my view, tools like these have become a regular part of how I screen and compare small-cap names during periods of volatility. Tickeron’s AI Screener lets me quickly filter for technical setups, fundamental metrics, and industry peers without manually digging through dozens of charts each time. It has helped surface ideas and confirm patterns in names like SOTK when earnings or policy shifts create sudden moves. The platform’s customizable signals and performance data make it straightforward to track momentum changes across the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
SOTK in downward trend: price dove below 50-day moving average on October 29, 2026
SOTK moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend. In 40 of 48 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SOTK as a result. In 85 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for SOTK turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 36 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
The 10-day moving average for SOTK crossed bearishly below the 50-day moving average on October 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for SOTK entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOTK advanced for three days, in 169 of 228 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
SOTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.279) is normal, around the industry mean (1.448). P/E Ratio (33.077) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (3.258) is also within normal values, averaging (32.028).
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. SOTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ElectronicEquipmentInstruments
Advertisement